Ephedrine-Induced Cardiac Ischemia: Exposure Confirmed with a Serum Level

Journal of Toxicology - Clinical Toxicology

Volumn 41, Issue 6, 2003, Pages 849-853

  Schier, Joshua G ^a,c   Traub, Stephen J ^a,b   Hoffman, Robert S ^a   Nelson, Lewis S ^a  

^a NEW YORK CITY POISON CONTROL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Cardiac; Ephedrine; Ischemia

Indexed keywords

CAFFEINE; EPHEDRINE; TROPONIN;

ABDOMINAL PAIN; ADULT; CASE REPORT; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EXPOSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; NAUSEA; SINUS RHYTHM; ST SEGMENT DEPRESSION; SYMPTOMATOLOGY; T WAVE; TREMOR; TRICUSPID VALVE REGURGITATION; VOMITING;

ADULT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EPHEDRINE; FEMALE; HUMANS; MYOCARDIAL ISCHEMIA; TROPONIN; VASOCONSTRICTOR AGENTS;

POMACANTHUS MACULOSUS;

EID: 0344271028     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120025350     Document Type: Conference Paper

References (13)

1. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Eng J Med 2000; 343(25):1833-1838.
2. Samenuk D, Link MS, Homoud MK, Contreras R, Theohardes TC, Wang PJ, Mark Estes NA III. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc 2002; 77:12-16.
3. Traub SJ, Hoyek W, Hoffman RS. Dietary supplements containing ephedra alkaloids. N Engl J Med 2001; 344(14):1096.
4. Cockings JGL, Brown MA. Ephedrine abuse causing acute myocardial infarction. Med J Aust 1997; 167(4):199-200.
5. Perrone J. Dieting agents and regimens. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 7th ed. New York: McGraw-Hill, 2002:571-577.
6. Johnson DA, Hricik JG. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy 1993; 13:110S-115S.
7. Haller CA, Jacob P III, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther 2002; 71(6):421-432.
8. Gurley BJ, Gardner SF, White LM, Wang PL. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther Drug Monit 1998; 20(4):439-445.
9. Berlin I, Warot D, Aymard G, Acquaviva E, Legrand M, Labarthe B, Peyron I, Diquet B, Lechat P. Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects. Eur J Clin Pharmacol 2001; 57:447-455.
10. White LM, Gardner SF, Gurley BJ, Marx MA, Wang PL, Estes M. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharm 1997; 37:116-122.
11. Pickup ME, May CS, Ssendagire R, Paterson JW. The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatment. Br J Clin Pharmacol 1976; 3:123-134.
12. Gurley BJ, Wang P, Gardner SF. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (ma-huang) as determined by high performance liquid chromatography. J Pharm Sci 1998; 87:1547-1553.
13. Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm 2000; 57:963-969.